Seshu Vardhan Pothabathula

Dr. Seshu Vardhan Pothabathula

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Life Sciences
Verified
Journal Article
Closed access
PKPrem Prakash Kushwaha
Prem Prakash Kushwaha
SPSeshu Vardhan Pothabathula
Seshu Vardhan Pothabathula
PKPetrina Kapewangolo
Petrina Kapewangolo
MSMohammad Shuaib
Mohammad Shuaib
SPSunita Kumari Prajapati
Sunita Kumari Prajapati
Shashank KumarShashank Kumar
Shashank Kumar

20 August 2020 in Photochemical & Photobiological Sciences
Verified
Journal Article
Closed access
PDF file
VBVinita Bhardwaj
Vinita Bhardwaj
ATAnand Thangaraj
Anand Thangaraj
SPSeshu Vardhan Pothabathula
Seshu Vardhan Pothabathula
SKS. K. Ashok Kumar
S. K. Ashok Kumar
Guido CrisponiGuido Crisponi
Guido Crisponi
SSSuban Sahoo
Suban Sahoo
Aggregation-induced emission (AIE) properties of an easy-to-prepare and structurally planar Schiff base derivative of the vitamin B6 cofactor pyridoxal (L) were investigated in DMSO–H2O mixed solvents. Compound L showed weak fluorescence (λem = 425 nm) in pure DMSO, but increasing the fraction of water in DMSO resulted in a significant fluorescence enhancement at 575 nm due to the restriction of intramolecular rotation (RIR) of L upon aggregation. SEM analyses revealed the formation of hairy micelle-like or needle-shaped self-assemblies/aggregates of L. The DFT calculations were performed to examine the tendency of L to form self-aggregates, and the results indicate the formation of several intramolecular non-covalent interactions that energetically favored the self-aggregation of L. The pH sensing study revealed that the red-emission of aggregates of L between pH 5.9 and 9.0 turned into green emission at the basic pH with the estimated pKa values of 9.39 and 10.22. Further, the aggregates of L were applied for the visualization of latent fingerprints (LFPs) over a non-porous glass slide.

21 December 2023 in Life
Verified
Journal Article
Open access
PDF file
RKRadha Kushwaha
Radha Kushwaha
SPSeshu Vardhan Pothabathula
Seshu Vardhan Pothabathula
PKPrem Prakash Kushwaha
Prem Prakash Kushwaha
Chronic kidney disease (CKD) poses a global health challenge, engendering various physiological and metabolic shifts that significantly impact health and escalate the susceptibility to severe illnesses. This comprehensive review delves into the intricate complexities of CKD, scrutinizing its influence on cellular growth homeostasis, hormonal equilibrium, wasting, malnutrition, and its interconnectedness with inflammation, oxidative stress, and cardiovascular diseases. Exploring the genetic, birth-related, and comorbidity factors associated with CKD, alongside considerations of metabolic disturbances, anemia, and malnutrition, the review elucidates how CKD orchestrates cellular growth control. A pivotal focus lies on the nexus between CKD and insulin resistance, where debates persist regarding its chronological relationship with impaired kidney function. The prevalence of insulin abnormalities in CKD is emphasized, contributing to glucose intolerance and raising questions about its role as a precursor or consequence. Moreover, the review sheds light on disruptions in the growth hormone and insulin-like growth factor axis in CKD, underscoring the heightened vulnerability to illness and mortality in cases of severe growth retardation. Wasting, a prevalent concern affecting up to 75% of end-stage renal disease (ESRD) patients, is analyzed, elucidating the manifestations of cachexia and its impact on appetite, energy expenditure, and protein reserves. Taste disturbances in CKD, affecting sour, umami, and salty tastes, are explored for their implications on food palatability and nutritional status. Independent of age and gender, these taste alterations have the potential to sway dietary choices, further complicating the management of CKD. The intricate interplay between CKD, inflammation, oxidative stress, and cardiovascular diseases is unraveled, emphasizing the profound repercussions on overall health. Additionally, the review extends its analysis to CKD’s broader impact on cognitive function, emotional well-being, taste perception, and endothelial dysfunction. Concluding with an emphasis on dietary interventions as crucial components in CKD management, this comprehensive review navigates the multifaceted dimensions of CKD, providing a nuanced understanding essential for developing targeted therapeutic strategies.

21 March 2023 in ACS Omega
Verified
Journal Article
Open access
NRNilmadhab Roy
Nilmadhab Roy
SSShanooja Shanavas
Shanooja Shanavas
BKBinoy Kar
Binoy Kar
LBLavanya Thilak Babu
Lavanya Thilak Babu
UDUtpal Das
Utpal Das
PPPriyankar Paira
Priyankar Paira
Triple-negative breast cancer (TNBC) is an extremely vicious subtype of human breast cancer having the worst prognosis along with strong invasive and metastatic competency. Hence, it can easily invade into blood vessels, and presently, no targeted therapeutic approach is available to annihilate this type of cancer. Metal complexes have successfully stepped into the anticancer research and are now being applauded due to their anticancer potency after the discovery of cisplatin. Many of these metal complexes are also well recognized for their activity toward breast cancer. As the TNBC is a very dangerous subtype and has long been a challenging ailment to treat, we have intended to develop a few brand new mixed metallic Ru(II)/Ir(III)/Re(I)-2,2'-bipyrimidine complexes [L'Re2], [L'RuRe], and [L'IrRe] to abate the unbridled proliferation of TNBC cells. The potency of the complexes against TNBC cells has been justified using MDA-MB-468 TNBC cell lines where complex [L'IrRe] has displayed significant potency among all the three complexes with an IC50 value of 24.12 μM. The complex [L'IrRe] has been competent to cause apoptosis of TNBC cells through inhibition of the G2/M phase in the cell cycle in association with a profuse amount of ROS generation and mitochondrial depolarization.

13 December 2021 in Journal of Traditional and Complementary Medicine
Verified
Journal Article
Open access
SPSeshu Vardhan Pothabathula
Seshu Vardhan Pothabathula
SSSuban Sahoo
Suban Sahoo
The ongoing global pandemic due to SARS-CoV-2 caused a medical emergency. Since December 2019, the COVID-19 disease is spread across the globe through physical contact and respiratory droplets. Coronavirus caused a severe effect on the human immune system where some of the non-structural proteins (nsp) are involved in virus-mediated immune response and pathogenesis. To suppress the viral RNA replication mechanism and immune-mediated responses, we aimed to identify limonoids and triterpenoids as antagonists by targeting helicases (nsp13), exonuclease (nsp14), and endoribonuclease (nsp15) of SARS-CoV-2 as therapeutic proteins. In silico molecular docking and drug-likeness of a library of 369 phytochemicals from limonoids and triterpenoids were performed to screen the potential hits that binds effectively at the active site of the proteins target. In addition, the molecular dynamics simulations of the proteins and their complexes with the potential hits were performed for 100 ns by using GROMACS. The potential compounds 26-deoxyactein and 25-O-anhydrocimigenol 3-O-beta-d-xylopyranoside posing strong interactions with a minimum binding energy of −10.1 and −9.5 kcal/mol, respectively and sustained close contact with nsp13 for 100 ns. The nsp14 replication fork activity was hindered by the tomentosolic acid, timosaponin A-I, and shizukaol A with the binding affinity score of −9.2, −9.2, and −9.0 kcal/mol, respectively. The nsp15 endoribonuclease catalytic residues were inhibited potentially by limonin, 25-O-anhydrocimigenol 3-O-alpha-l-arabinopyranoside, and asperagenin posing strong binding affinity scores of −9.0, −8.8, and −8.7 kcal/mol, respectively. Computationally predicted potential phytochemicals for SARS-CoV-2 are known to possess various medicinal properties.

30 May 2024 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BKBinoy Kar
Binoy Kar
SSShanooja Shanavas
Shanooja Shanavas
AKArun Karmakar
Arun Karmakar
ANApoorva H. Nagendra
Apoorva H. Nagendra
SPSeshu Vardhan Pothabathula
Seshu Vardhan Pothabathula
PPPriyankar Paira
Priyankar Paira